Sensei Biotherapeutics, Inc.

NASDAQ:SNSE

0.49 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Operating Activities:
Net Income -7.142-7.992-7.414-7.124-9.386-10.177-12.232-13.416-10.535-12.405-9.366-9.685-9.771-7.972-5.131-5.367-4.91-4.692-6.705
Depreciation & Amortization 0.1350.1370.1350.3320.3320.3580.3510.3420.320.3340.3290.1360.1220.0980.070.0640.0520.0230.023
Deferred Income Tax 000.356-0.214-0.142000000.199-0.3530.1730000-1.041.827
Stock Based Compensation 0.7951.2161.0981.0481.0951.2131.3991.4791.4191.5150.8261.7361.7461.3490.3540.7810.1630.1940.391
Change In Working Capital 0.085-1.427-0.40.979-1.715-3.1940.6554.545-3.525-0.6670.0932.5881.681-4.2452.023-1.2781.384-2.5261.621
Accounts Receivables 0000000000000000000
Change In Inventory 0000000000000000000
Change In Accounts Payables -0.3540.306-0.7810.471-2.2630.2422.0172.234-2.6772.644-1.0180.740.732-1.882.812-2.5241.151-1.1041.624
Other Working Capital 0.439-1.7330.3810.5080.548-3.436-1.3622.311-0.848-3.3111.1111.8480.949-2.365-0.7891.2460.233-1.422-0.003
Other Non Cash Items 1.7541.6340.0620.3180.3530.0640.2530.2470.4220.4730.0510.0010.0020.0030.0040.0020.5441.5811.192
Operating Cash Flow -5.792-7.616-6.163-4.661-9.463-11.736-9.574-6.803-11.899-10.75-7.868-5.577-6.047-10.767-2.68-5.798-2.767-6.46-1.651
Investing Activities:
Investments In Property Plant And Equipment -0.109-0.03700-0.029-0.151-0.071-0.25-0.052-0.019-0.535-0.388-0.616-0.487-0.316-0.836-0.002-0.052-0.044
Acquisitions Net 00-0.16600.1570.00900.015-0.0130-120.88600000-000
Purchases Of Investments -11.734-6.259-2.613-8.688-0.002-9.84618.148-21.748-35.252-8.017-9.853-26.671-147.145000000
Sales Maturities Of Investments 18.7512.06610.8751719.412.3-2.10530.548.520.2291626.2590000000
Other Investing Activites 00.0060.1660.0080.020.0020.0710.0090.0130.012120.88626.577-147.145000-0.19700
Investing Cash Flow 6.9075.778.2628.31219.5262.31216.0438.51713.19612.1935.612-0.482-147.761-0.487-0.316-0.836-0.199-0.052-0.044
Financing Activities:
Debt Repayment -0.201-0.199-0.196-0.19-0.189-0.186-0.177-0.163-0.156-0.133-0-0-0-0-0.01-0.01-0.011-0.01-0.008
Common Stock Issued 000.0480000.238000.2380.029023.491140.5950.5410000
Common Stock Repurchased 0-0-0.252-2.344-7.788-00000000000000
Dividends Paid 0000000000000000000
Other Financing Activities 0.021-0.01-0.031-0.010.031-0.076-0.185-00.0370.2520000.16415.3288.4910.56710.5671.654
Financing Cash Flow -0.18-0.209-0.431-2.534-7.946-0.262-0.124-0.163-0.1190.119-0-0-00.16415.8598.4810.55610.5571.646
Other Information:
Effect Of Forex Changes On Cash 0011.5030-11.50300000000000000
Net Change In Cash 0.935-2.0551.6681.1172.117-9.6866.3451.5511.1781.562-2.374-6.066-153.819152.82212.8631.847-2.414.045-0.049
Cash At End Of Period 11.89110.95613.01111.34310.2268.10917.79511.459.8998.7217.1599.53315.599169.41816.5963.7331.8864.2960.251